DR Congo Ebola Crisis Surpasses 2,300 Deaths to Become Country's Deadliest on Record

Red Cross volunteers in the Democratic Republic of the Congo carry the body of an Ebola victim on June 8, 2026 [AFP]. The Ebola outbreak in the Democratic Republic of the Congo (DRC) has claimed 2,325 lives, exceeding the mortality figures of the 2018-2020 crisis and establishing itself as the most lethal in the nation's history.

Data released on Sunday by the DRC's National Public Health Institute indicates that total confirmed infections have reached 4,945, which includes 101 newly reported cases within the preceding 24 hours.

United Nations humanitarian chief Tom Fletcher described the crisis in a Friday statement, emphasizing that it represents the fastest-growing outbreak on record and requires immediate speed, scale, and international solidarity.

Marking the DRC's 17th Ebola incident, the current situation surpassed previous milestones in late July by becoming the largest in terms of case volume. Government statistics confirm that the death toll has now exceeded the 2,299 fatalities registered during the 2018-2020 period.

Addressing the ongoing response, Fletcher warned that the virus is currently outpacing containment efforts. On Wednesday, World Health Organization Director-General Tedros Adhanom Ghebreyesus noted that the outbreak's trajectory could potentially rival the 2014-2016 West African epidemic.

The current transmission is driven by the Bundibugyo species of Ebola virus, for which no approved treatments or vaccines currently exist. Officials cite regional conflict, geographical remoteness, and fragile health infrastructure near the borders of South Sudan, Uganda, and Rwanda as major obstacles since the outbreak was declared on May 15.

Government figures show that the case fatality ratio has climbed from approximately 20 percent in early June to 46 percent, meaning roughly one out of every two confirmed patients is succumbing to the virus.

Thomas Parisch, a public health specialist with Doctors Without Borders (MSF), explained that unlike typical outbreaks where mortality rates decline over time due to improved contact tracing, healthcare workers are continuing to encounter delayed diagnoses and post-mortem community detections.

Health authorities are currently evaluating a limited supply of experimental vaccines and therapies, though evidence supporting existing treatments remains largely restricted to animal studies.